Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

52Fe for additional marrow ablation before bone marrow transplantation

A Ferrant1, M Cogneau, N Leners

  • 1Department of Hematology, Catholic University of Louvain, Belgium.

Blood
|June 15, 1993
PubMed
Summary

Iron-52 (52Fe) radiotherapy selectively targets bone marrow (BM) in patients with malignant blood diseases undergoing bone marrow transplantation (BMT). This approach enhances BM radiation dose without increasing toxicity, offering a promising strategy for improving BMT outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic value of [18F]FDG-PET/CT for treatment monitoring in large vessel vasculitis: a systematic review and meta-analysis.

European journal of nuclear medicine and molecular imaging·2021
Same author

Diagnostic value of [18F]FDG-PET/CT in polymyalgia rheumatica: a systematic review and meta-analysis.

European journal of nuclear medicine and molecular imaging·2020
Same author

<sup>90</sup>Y TOF-PET based EUD reunifies patient survival prediction in resin and glass microspheres radioembolization of HCC tumours.

Physics in medicine and biology·2018
Same author

Clinical indications, image acquisition and data interpretation for white blood cells and anti-granulocyte monoclonal antibody scintigraphy: an EANM procedural guideline.

European journal of nuclear medicine and molecular imaging·2018
Same author

Translocation (14;19)(q32;q13.1) in a Young Patient who Developed a Large Cell Lymphoma after an Initial Diagnosis of CLL.

Leukemia & lymphoma·2016
Same author

Practical Epidemiology.

Acta clinica Belgica·2016

Area of Science:

  • Nuclear Medicine
  • Hematology
  • Oncology

Background:

  • Bone marrow transplantation (BMT) effectiveness for malignant blood diseases is limited by preparative regimen toxicity.
  • Selective radiotherapy delivery to bone marrow (BM) is needed to improve disease elimination without organ damage.

Purpose of the Study:

  • To evaluate the safety and efficacy of using Iron-52 (52Fe) for targeted radiotherapy in patients undergoing BMT.
  • To determine the radiation dose delivered to the BM, liver, and whole body using 52Fe.

Main Methods:

  • Fourteen patients with hematologic malignancies received 52Fe before conventional BMT conditioning.
  • Quantitative scanning assessed 52Fe uptake in BM and liver.
  • Radiation-absorbed doses to BM, liver, and whole body were calculated.

Related Experiment Videos

Main Results:

  • Median 52Fe dose was 58 mCi, with 82% uptake in the BM, delivering a median dose of 632 rad.
  • Median liver uptake was 18%, resulting in a median dose of 239 rad.
  • No significant toxicity was observed, and patients recovered hematopoiesis within expected limits.

Conclusions:

  • 52Fe administration is a safe method to boost radiation dose to marrow-based diseases prior to BMT.
  • This technique can enhance disease eradication without increasing toxicity, potentially improving BMT outcomes for hematologic malignancies.